Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 5 Listed Suppliers, $ API Reference Price

5 API Suppliers
5 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 Listed Dossiers

2 FDF Dossiers
2 Listed Dossiers

DIGITAL CONTENT

24 NEWS #PharmaBuzz

media
24 NEWS #PharmaBuzz

MARKET PLACE

6 APIs

marketPlace
6 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 495399-09-2, Lipaglyn, Zyh1, Saroglitazar [inn], (s)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1h-pyrrol-1-yl)ethoxy)phenyl)propanoic acid, E0ymx3s4jd

Molecular Formula

C₂₅H₂₉NO₄S

Molecular Weight

439.6 g/mol

InChI Key

MRWFZSLZNUJVQW-DEOSSOPVSA-N

FDA UNII

E0YMX3S4JD

Saroglitazar has been investigated for the treatment of Fatty Liver.

1 2D Structure

Saroglitazar

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2S)-2-ethoxy-3-[4-[2-[2-methyl-5-(4-methylsulfanylphenyl)pyrrol-1-yl]ethoxy]phenyl]propanoic acid

2.1.2 InChI

InChI=1S/C25H29NO4S/c1-4-29-24(25(27)28)17-19-6-10-21(11-7-19)30-16-15-26-18(2)5-14-23(26)20-8-12-22(31-3)13-9-20/h5-14,24H,4,15-17H2,1-3H3,(H,27,28)/t24-/m0/s1

2.1.3 InChI Key

MRWFZSLZNUJVQW-DEOSSOPVSA-N

2.1.4 Canonical SMILES

CCOC(CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O

2.1.5 Isomeric SMILES

CCO[C@@H](CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O

2.2 Other Identifiers

2.2.1 UNII

E0YMX3S4JD

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (2s)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylsulfanyl)phenyl)-1h-pyrrol-1-yl(ethoxy)phenyl)propanoic Acid

2. (2s)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylsulfanyl)phenyl)-1h-pyrrol-1-yl(ethoxy)phenyl)propanoic Acid Magnesium Salt (2:1)

3. Alpha-ethoxy-4-(2-(2-methyl-5-(4-methylthio)phenyl))-1h-pyrrol-1-yl)ethoxy))benzenepropanoic Acid

4. Alpha-ethoxy-4-(2-(2-methyl-5-(4-methylthio)phenyl))-1h-pyrrol-1-yl)ethoxy))benzenepropanoic Acid Magnesium Salt

5. Lipaglyn

6. Saroglitazar Magnesium

7. Zyh1 Compound

2.3.2 Depositor-Supplied Synonyms

1. 495399-09-2

2. Lipaglyn

3. Zyh1

4. Saroglitazar [inn]

5. (s)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1h-pyrrol-1-yl)ethoxy)phenyl)propanoic Acid

6. E0ymx3s4jd

7. 495399-09-2 (free)

8. (2s)-2-ethoxy-3-[4-[2-[2-methyl-5-(4-methylsulfanylphenyl)pyrrol-1-yl]ethoxy]phenyl]propanoic Acid

9. Unii-e0ymx3s4jd

10. Saroglitazarum

11. Saroglitazar [who-dd]

12. Chembl4297530

13. Schembl16346340

14. Dtxsid10197819

15. Chebi:134708

16. Bcp25470

17. Vua39909

18. Mfcd28502034

19. S9674

20. Cs-6149

21. Db13115

22. (2s)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylsulfanyl)phenyl)-1h-pyrrol-1-yl(ethoxy)phenyl)propanoic Acid

23. Hy-19937

24. P14958

25. A913988

26. Q15269693

27. (2s)-2-ethoxy-3-[4-(2-{2-methyl-5-[4-(methylthio)phenyl]-1h-pyrrol-1-yl}ethoxy)phenyl]propanoic Acid

28. (s)-alpha-ethoxy-4-[2-[-methyl-5-[4-(methylthio) Phenyl]-1h-pyrrol-1-yl]ethoxy]benzene-propanoic Acid

29. Benzenepropanoic Acid, .alpha.-ethoxy-4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1h-pyrrol-1-yl)ethoxy)-, (.alpha.s)-

2.4 Create Date

2012-09-10

3 Chemical and Physical Properties

Molecular Formula	C₂₅H₂₉NO₄S
Molecular Weight	439.6 g/mol
XLogP3	4.9
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	11
Exact Mass	439.18172958 g/mol
Monoisotopic Mass	439.18172958 g/mol
Topological Polar Surface Area	86 Å²
Heavy Atom Count	31
Formal Charge	0
Complexity	532
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

API SUPPLIERS

01

Omgene Life Sciences Pvt. Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPhI India 2024

Attending

Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

02

Taizhou Crene Biotechnology

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharma Manufacturing 2024

Not Confirmed

03

SynInnova Laboratories

Canada

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharma Manufacturing 2024

Not Confirmed

04

Tian Yuan Pharm

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharma Manufacturing 2024

Not Confirmed

05

Artis Biotech

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharma Manufacturing 2024

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

01

Omgene Life Sciences Pvt. Ltd

India

CPhI India 2024

Attending

Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Contact Supplier

India

Virtual Booth

Digital Content

Saroglitazar

About the Company : Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically...

Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically integrated company, we focus on developing high-quality formulations based on in-house-produced actives. With GMP-certified facilities and partnerships with contract manufacturers, we excel in formulation development for injectables, lyophilized injectables, complex generics, and oral peptide delivery systems, ensuring affordable, top-quality medicines.